You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

January 5, 2018

APFI Food Safety Regulations Series: Vietnam

Asia Pacific Food Industry (APFI)

To better understand the food regulatory landscape in Asia, APFI has spoken to law firms that specialize in food law from five different countries across Asia, which include China, Thailand, Vietnam, Singapore and the Philippines. 

In the third part of the series, we look at food safety regulations in Vietnam. Hien Thi Thu Vu, head of regulatory affairs, Vietnam, Tilleke & Gibbins, shares her advice.

How do food regulation and registration vary depending on the product or category?

Food products, depending on the product category, are regulated and managed by three different ministries: the Ministry of Health (MOH), the Ministry of Industry and Trade (MOIT), and the Ministry of Agriculture and Rural Development (MARD). The MOH has the prevailing general management power.

These ministries have issued three lists of foods, specifying which food belongs to the management of which ministry. The MOH, for example, is in charge of bottled water, functional foods, and nutraceuticals; the MOIT is in charge of wine, beer, and candy; and the MARD is in charge of cereals, meat and meat products, and seafood. This classification affects a number of things, including which authority carries out food safety inspection.

Regardless of their categories, all foreign processed foods must be registered with the Vietnam Food Administration (VFA)—an agency of the MOH—to obtain a Certificate of Conformity Declaration (CCD) before being imported into and/or circulated in the Vietnam market.

Processed foods include two main groups: general food products, and nutraceuticals/functional food products. Depending of the group, food products may have to meet different requirements before getting the CCD. For example, a functional food must have a Free Sale Certificate or Health Certificate or an equivalent certificate granted by competent authorities in the country of origin, along with information and scientific documents supporting the effects of each ingredient contributing to the declared functions of the product. General food products are exempt from these requirements, but must provide testing results from within the past 12 months, including key quality criteria and food safety criteria.

It is strictly required that product labels comply with the country’s labelling requirements, such as compulsory contents in the Vietnamese language.

Have you seen a growth in the number of food and beverage companies entering the markets in Vietnam?

Yes, the market is growing fast and the game is growing more and more competitive. Food and beverage conferences and exhibitions regularly attract hundreds of companies from Europe, Asia, and the Americas looking to introduce their products to the Vietnam market, and business advocates like the European Business Network in Vietnam and the American Chamber of Commerce have organized trade promotion activities in sectors such as canned food, milk, beer, and wine. The launch of the European Union-Vietnam Free Trade Agreement is certain to open the market further to European food and beverage companies.

At present, many foreign businesses are investing in the country’s food and beverage market through mergers and acquisitions to own shares in many of the nation’s domestic companies, such as Kido Group, Dabaco, and Masan Nutri-Science. More than 50 percent of the local beverage market is now owned by foreign businesses.

Which regulatory hurdles should manufacturers be aware of when entering the food market in Vietnam?

When it comes to preparing for market launch, there are some regulatory hurdles that foreign food manufacturers and distributors will inevitably encounter in Vietnam.

The general regulations on the levels, criteria, and requirements for heavy metals, pollutants, microorganisms, etc., related to food safety and hygiene for human health issued by the Ministry of Health have not been updated since 2011, and are not in line with corresponding standards in other countries where the products are often produced.

Although there is an online submission system for registering products in Vietnam, government agencies still require manufacturers to submit original documents such as the Certificate of Analysis, Hazard Analysis and Critical Control Points, and ISO 22000 certificates. This slows down the registration process of the product.

Some labelling regulations are not flexible enough to cover exceptions in special cases, such as beverages sold exclusively to bars, and food sold exclusively to manufacturers’ store systems.

Foods circulating in the market are subject to periodic quality testing. At present, however, many labs in Vietnam do not have high-quality operations, which can lead to inaccurate test results, affecting the test quality of products. This in turn can lead to products not being in conformity with the documents registered with government agencies. In this case, the CCD might be revoked, and a sanction may be imposed against the seller/importer.

One common violation of food products is in labelling, when the information on the label is different from the information submitted to the VFA or when the label changes without notice being sent to the VFA. This can result in a fine being imposed on the seller/importer, and the goods being withdrawn from the market. Manufacturers should closely monitor any changes in their products and labels to ensure compliance.

Do you predict any major changes to transpire in Vitnam’s food industry in the next five to ten years?

With a population approaching 100 million, strong gross domestic product growth, rising per capita income, rapid urbanization, and growing concerns about food safety from consumers, Vietnam’s market is promising even more growth and development in the coming time, especially for foreign manufacturers.

The legal regulations for food and drinks are becoming more transparent. There have been some updates of regulatory requirements which facilitate the market launch of products. For example, online submission will be encouraged for registration of food and beverage products, and this process is expected to save time and money for suppliers.

The safety and quality of food is a growing concern for consumers as well as state regulators:

  • Products from highly reputable foreign companies, especially in baby food and health foods, will be more and more in demand.
  • State management agencies will intensify the frequency of inspection of various stages of the manufacturing processes. Non-compliant activities could lead to sanctions such as product recall.

Are there any other thoughts you would like to share with our readers?

Already promising and potentially hugely profitable, the food and beverage market is still growing. There will be increasingly more room and opportunity for foreign manufacturers. In parallel with income growth, consumers are becoming increasingly more selective about their food and drink purchases, particularly the quality and safety of the products, and are willing to spend more for a better choice.

Though seemingly clear and detailed, Vietnam’s legal regulations can be unpredictable in practice, with many grey areas, jurisdictional overlap, and contradictions to cope with. However, we believe that with the growing effort of the government to cut through the red tape, the regulatory hurdles will be significantly lowered in the future.

Please provide an overview of what the firm does.

Tilleke & Gibbins is a regional law firm in Southeast Asia, with 150 lawyers and consultants in Bangkok, Hanoi, Ho Chi Minh City, Jakarta, Phnom Penh, Vientiane, and Yangon. We represent investors and companies in the key areas of commercial transactions as well as mergers and acquisitions, dispute resolution and litigation, and intellectual property.

One of our important practice areas is regulatory affairs, where we assist companies in the pharmaceutical, cosmetics, consumer products, food and beverages, biotech, medical devices, veterinary products, and other life sciences sectors to enter markets throughout Southeast Asia. We assist companies in research and development and clinical trials to registration and market entry to commercialization and technology transfer, through every stage of a product’s life cycle.

Our Regulatory Affairs practice spans the following disciplines:

  • Clinical Trials and Consumer Testing
  • Registration with Vietnam Food Administration (VFA) or Drug Administration of Vietnam (DAV)
  • Import, Export, and Manufacturing Licenses
  • Ministry of Agriculture and Rural Development (MARD) Crop Care Registration
  • MARD Animal, Aquatic, and Hazardous Substance Registration
  • MARD Import, Export, and Manufacturing Licenses
  • Regulatory Compliance and Maintenance
  • Labeling and Advertising Clearance
  • Intellectual Property

Article by Farah Nazurah Source: http://apfoodonline.com/industry/food-safety-regulations-series-vietnam/

RELATED INSIGHTS​ 

July 15, 2025
On July 1, 2025, Vietnam’s Ministry of Health issued Circular No. 30/2025/TT-BYT providing updated guidance on the application of drug quality standards, testing of drugs and pharmaceutical ingredients, and procedures for the recall and handling of noncompliant drugs (Circular 30). Circular 30 officially came into effect on the same day and replaces Circular No. 11/2018/TT-BYT and its amendments. Key highlights of Circular 30 are presented below. Drug and Pharmaceutical Ingredient Quality Standards Circular 30 maintains consistency with previous regulations regarding the selection of an applicable quality specification. Pharmaceutical businesses and drug preparation establishments may still choose to apply standards from the Vietnamese Pharmacopoeia, reference pharmacopoeias (including the United States Pharmacopoeia, the European Pharmacopoeia, the British Pharmacopoeia, the Japanese Pharmacopoeia, and the International Pharmacopoeia), or an in-house specification. Priority is given to the Vietnamese Pharmacopoeia and reference pharmacopoeias, encompassing quality indicators, quality levels, and testing methods. If alternative pharmacopoeias or in-house specifications are used, they must meet the requirements outlined in the corresponding monographs of the Vietnamese or reference pharmacopoeias. At the time of registration, the quality standards of drugs and pharmaceutical ingredients must comply with either the current version of the pharmacopoeia or a previous version of the pharmacopoeia that is no more than two years older than the current version. The requirement for updating quality specifications in line with the quality under the corresponding pharmacopoeia also applies to products that have already been granted marketing authorization. Testing Drugs and Pharmaceutical Ingredients in Quality Management Similar to the regulations under the previous circular, if pharmaceutical businesses disagree with the sample testing results, they may, within five working days of receiving the test report, request that the state quality inspection authority designate an alternative testing facility. The testing period for establishments listed as foreign drug manufacturers with quality violations remains
July 14, 2025
Life sciences specialists from Tilleke & Gibbins have updated the firm’s guide to pharmaceutical data exclusivity regulations and practices in Southeast Asia. This guide contains quick-reference information on the availability of data exclusivity protections and limitations in Cambodia, Indonesia, Laos, Malaysia, Myanmar, Thailand, and Vietnam. Developing and launching a new drug on a commercial scale requires an enormous amount of time and investment in research and development (R&D), including pre-clinical testing and clinical trials. When considering the aggregate amount of drug development costs, it is important to recognize that this includes not only the investment in developing new drugs that get approved by a government food and drug regulator and are successfully brought to market, but also the R&D expenditures on a large number of potential pharmaceutical compounds and products that never actually make it to market. In particular, considerable investment is required in order to conduct and produce clinical trial data—to prove safety, efficacy and effectiveness of a new drug—that would warrant marketing approval by the regulatory authority. Such data is proprietary in nature and highly valuable for a research-based pharmaceutical company that develops an original drug. On the other hand, patent law typically confers generic drug manufacturers with the ability to engage in various preparatory activities with a view to obtaining marketing approval for a generic product before the patent for the original drug expires (commonly known as a “Bolar provision”). Since a generic drug maker may submit an application for marketing approval of a generic product before the relevant patent expires, the extent to which the drug originator’s data submitted to the regulatory authority is protected—or in other words, the extent to which the generic company may rely on the drug originator’s previously filed data, which underpins the safety and efficacy of the drug, to support
July 8, 2025
On July 3, 2025, Vietnam’s Ministry of Health (MOH) issued Circular No. 34/2025/TT-BYT amending some articles of Circular No. 06/2011/TT-BYT on the management of cosmetics products (Circular 34), which provides the current regulations on the product notification process for cosmetics (cosmetic notification). Circular 34 will come into effect on August 18, 2025. Changes to Cosmetic Notification Some of the key stipulations of Circular 34 are outlined below. Addition of submission route for notification Circular 34 officially adds online submission via the National Public Service Portal as an accepted type of cosmetic notification, in addition to direct submission and submission via post. Clearer regulations on preparing cosmetic notification form Circular 34 provides clarification on the signing requirements for cosmetic notification forms. For online submissions, both e-signatures and digital signatures are accepted. For offline submissions, the circular explicitly states that stamped/generated signatures are not acceptable. There are no substantive changes to existing requirements regarding grouping of products in a single declaration, ingredient listing, or language used in the notification form. Circular 34 only introduces formatting adjustments to these provisions. Updated administrative procedures Circular 34 updates requirements on digital procedures and authentication for online submission with references to new government decrees. In addition, processing timelines for cosmetic notification are further clarified, in particular, five working days for feedback on incomplete dossiers and five working days for approval after receiving complete supplemental dossiers. Revised requirements for import of samples for testing and research An updated Appendix 14-MP form is introduced with Circular 34, in which the receiving authority is updated from the Drug Administration of Vietnam to the specialized health agency under the provincial People’s Committee. Both online and direct submission of the request are allowed. The approval timeline is three working days from the date of reviewing the request. Transition clause Notifications
July 8, 2025
On June 29, 2025, the government of Vietnam issued Decree No. 163/2025/ND-CP providing detailed guidance on the implementation of the amended Law on Pharmacy (Decree 163). Decree 163, like the amended Law on Pharmacy, took effect on July 1, 2025, officially replacing Decree No. 54/2017/ND-CP (Decree 54). The new decree introduces comprehensive regulations across key areas of pharmaceutical management such as pharmacy practice certificates, certificates of eligibility for pharmaceutical business, import and export of drugs and drug materials, GMP inspection of foreign manufacturers, drug and drug material recall, certificates of drug advertising content, and drug price management. Key Changes in Decree 163 Some outstanding changes and additions in Decree 163 are presented below. Destruction of Specially Controlled Drugs It is no longer required to obtain approval from the competent authority before the destruction of narcotic, psychotropic, and precursor drugs, and pharmaceutical ingredients that are narcotic or psychotropic substances, or precursors used in drugs. Instead, notification must be provided at least seven working days in advance, including the proposed destruction date and a detailed list of items to be destroyed. E-commerce in Pharmaceuticals Pharmaceutical businesses operating via e-commerce platforms must publicly disclose the following information to ensure transparency and consumer safety: (i) certificate of eligibility for pharmaceutical business, (ii) pharmacy practice certificate of the person responsible for pharmaceutical expertise, and (iii) drug information. Shelf-Life Requirements for Imported Products For drugs and ingredients with a total shelf life of nine months or less, at least one-third of the shelf life must remain at the time of customs clearance. Drugs with a shelf life of 30 days or less must still be within their shelf life at the time of clearance. Control of Imported Products Drugs subject to import control include all drugs with marketing authorization (MA), except for (i) drugs that